September 11, 2024

MONTREAL – $2,000,000 to Support Prostate Cancer Research Through a Strategic Partnership

PROCURE is proud to announce a strategic partnership with the Cancer Research Society. This collaboration marks a new milestone in our ongoing commitment to support innovative research and improve treatments for prostate cancer patients.

A New Alliance in 2024

Today, we are excited to partner with the Cancer Research Society. This new collaboration underscores our unwavering commitment to supporting cutting-edge research initiatives and providing innovative solutions for patients and their families. Together, we will equally invest a total of $2 million over the next three years, funding four research projects of $500,000 each.

“We are deeply committed to establishing partnerships with various collaborators to advance science. Our announcement of collaborating with the Cancer Research Society adds to this valuable list of partners and symbolizes a major step forward in our mission. Together, we aim to push the boundaries of innovation and offer a better future to patients affected by prostate cancer,” says Laurent Proulx, CEO of PROCURE.

“This exceptional partnership with PROCURE allows us to strengthen our support for prostate cancer research, one of the most common cancers among men in Canada. Together, we have the opportunity to advance knowledge and treatments, offering precious hope to patients,” concludes Manon Pepin, CEO of the Cancer Research Society.

Expanding Collaborations

PROCURE is intensifying its efforts to establish strong partnerships with leading organizations. In 2022, we collaborated with the Cedars Cancer Foundation and the Terry Fox Foundation, entities recognized for their significant contributions to cancer research and patient support. In 2023, we joined forces with the Quebec Urological Association Foundation and the Canadian Urological Association Scholarship Foundation, further expanding our network of specialists and enhancing our impact on the medical community.

Our Ongoing Commitment

This series of partnerships clearly demonstrates our dedication to creating effective synergies with organizations that share our values. Through these alliances, we have been able to strengthen our support for patients, increase funding dedicated to research, and raise public awareness about the importance of prostate cancer detection and treatment. By aligning our efforts with those of the Cancer Research Society, we hope not only to enhance our current impact but also to open new avenues for more effective treatments and improved patient outcomes. We remain committed to advancing our mission and making significant progress in the fight against prostate cancer.

Details about the eligibility for the four $500,000 grants will be shared in early April 2025.